Breaking News Headlines Today | Ground News

Black Friday Sale - Get 40% off Vantage

Managed Healthcare Executive image

News from Managed Healthcare Executive

Managed Healthcare Executive’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Managed Healthcare Executive’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Managed Healthcare Executive

Where is Managed Healthcare Executive located?Managed Healthcare Executive's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Managed Healthcare Executive News

Louisiana Surgeon General, a Vaccine Critic, Named CDC Principal Deputy Director — REUTERS / pwu404

CDC · United States

Louisiana Surgeon General, a Vaccine Critic, Named CDC Principal Deputy Director

73% Center coverage: 48 sources

A Louisiana health official who ordered his health department to stop promoting mass vaccinations this past winter during a surge in influenza cases has been tapped to serve as the new number two leader at the Centers for Disease Control. See the Story

Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (Onasemnogene ...

Pharma · United States

Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (Onasemnogene ...

60% Center coverage: 25 sources

New York, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today called the U.S. Food and Drug Administration’s approval of Itvisma (onasemnogene abeparvovec-brve), developed by Novartis, a major step forward for families living with spinal muscular atrophy…See the Story

Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

Novo Nordisk · United States

Medicare negotiates 71% discount on Novo’s Ozempic, Wegovy

100% Center coverage: 1 sources

The U.S. government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly. Read more...See the Story

Breaking News Topics Related to Managed Healthcare Executive